Brief: Sandoz H1 Sales USD 5,232 Million
07/08/2025 06:00
Aug 07 (Reuters) - Sandoz H1 adjusted EBITDA margin 20%. H1 adjusted EPS USD 1.46
Recent news on Sandoz AG
See all newsPfizer dismissed from US states' drug price-fixing lawsuit (updated)
Pfizer dismissed from US states' drug price-fixing lawsuit
Factbox: Major investment pledges at Choose France summit
Press Digest: Financial Times - June 1
Media: Sandoz warns cheap Chinese imports threaten Europe’s antibiotic supply- FT